Sort
85,873 grants matching “alzheimers”
INDIANAPOLIS-IBADAN DEMENTIA PROJECT
$1,597,999Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2004 · AG
Community Engagement, Recruitment and Retention (CERR) Core D
$1,597,958Zhao Chen · University Of Arizona · U19 · FY2023 · AG
Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder
$1,597,923James M Bjork · Virginia Commonwealth University · U01 · FY2022 · DA
Contributions of stress reactivity to risk of Alzheimer's disease and related dementia's in a community-based cohort
$1,597,900Kiarri N Kershaw · Northwestern University At Chicago · R01 · FY2022 · AG
Cellular-level Vascular Oculomics (CVO) for monitoring systemic vascular health
$1,597,595Amani A Fawzi · Northwestern University At Chicago · OT2 · FY2024 · OD
Discovery of novel TDP-43 splicing targets: the Achilles heel for FTD and towards sensitive biomarkers and therapeutic targets
$1,597,452Aaron D. Gitler · Stanford University · U54 · FY2023 · NS
INDIANAPOLIS-IBADAN DEMENTIA PROJECT
$1,597,448Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2002 · AG
A system approach to targeting innate immunity in AD
$1,597,190Todd E. Golde · University Of Florida · U01 · FY2015 · AG
Commercialization Readiness for a Portable PET Insert System for Simultaneous TOF-PET and MR Brain Imaging
$1,596,935Chenming Chang · Petcoil, Inc. · SB1 · FY2025 · MH
Single molecule studies of protein binding and aggregation
$1,596,578Hoi Sung Chung · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Neurobiology of Alzheimer's Disease and Aging
$1,596,519Roger Rosenberg · Ut Southwestern Medical Center · P30 · FY2006 · AG
Brain Health and Ethnic Disparities in ADRD Risk: The Case of Arab Americans
$1,596,379Toni Claudette Antonucci · University Of Michigan At Ann Arbor · R01 · FY2023 · AG
IND Enabling Studies for a Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Alzheimer's Disease Related Dementia
$1,596,374Meredith Hay · University Of Arizona · U01 · FY2021 · AG
Novel Cognitive and Functional Measure for Alzheimer's Disease Prevention Trials
$1,595,795Terry Goldberg · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2018 · AG
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
$1,595,511Li-Huei Tsai · Massachusetts Institute Of Technology · U01 · FY2021 · AG
Effect of Suvorexant on Alzheimer's Disease Biomarkers
$1,595,468Brendan Patrick Lucey · Washington University · R01 · FY2023 · AG
Metabolic Control Analysis
$1,595,457Richard L Veech · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2020 · AA
Modulation Of Neuronal Channels and Receptors in the Brain
$1,595,360Jerrel L Yakel · Environmental Health Sciences · Z01 · FY2007 · ES
A Phase 3 Pivotal Trial of AGB101 to Slow Progression in MCI due to Alzheimer's Disease
$1,595,216Richard C. Mohs · Agenebio, Inc. · R01 · FY2022 · AG
Functional Genomic Dissection of Alzheimer's Disease in Humans and Drosophila Models
$1,594,999Joshua M Shulman · Baylor College Of Medicine · U01 · FY2023 · AG
Long-term, non-clinical toxicology for advancing CMS121 to Phase 2 trials for AD
$1,594,649William C Raschke · Virogenics, Inc. · U01 · FY2024 · AG
National Brain and Tissue Resource for Parkinson's Disease and Related Disorders
$1,594,500Thomas G Beach · Banner Health · U24 · FY2014 · NS
Lifecourse food insecurity and dementia risk
$1,594,439Suzanna M Martinez · University Of California, San Francisco · RF1 · FY2025 · AG
Collaboration, Communication, and Coordination Center for ADSP (ADSP-4C)
$1,594,366Kenneth M. Rice · University Of Washington · U01 · FY2025 · AG
Health and Aging in Africa: Longitudinal Studies of an INDEPTH Community
$1,593,852Lisa F Berkman · Harvard School Of Public Health · P01 · FY2020 · AG